Shire Acquires Lotus Tissue Repair, Inc.
HGT Pipeline Enhanced with Protein Replacement Therapy Being
Investigated for the Treatment of Dystrophic Epidermolysis
Bullosa
LEXINGTON,
Massachusetts, January 8, 2013
/PRNewswire/ --Shire plc (LSE: SHP, NASDAQ: SHPG), announces that
it has...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news